Pseudo-acylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid-deficient rats and has an inhibitory effect on epidermal hyperplasia
about
The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramideMalnutrition-associated rash of cystic fibrosis.Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response.Skin hydration in postmenopausal women: argan oil benefit with oral and/or topical use.On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramidesPNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis.Subclinical cutaneous inflammation remained after permeability barrier disruption enhances UV sensitivity by altering ER stress responses and topical pseudoceramide prevents them.Investigation into the dosage of dietary sphingomyelin concentrate in relation to the improvement of epidermal function in hairless mice.Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.Does Argan oil have a moisturizing effect on the skin of postmenopausal women?Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis.Fractionated aliphatic alcohols as synthetic precursors of ultra long-chain monoacylglycerols for cosmetic applications.Reevaluation of the non-lesional dry skin in atopic dermatitis by acute barrier disruption: an abnormal permeability barrier homeostasis with defective processing to generate ceramide.Novel synthetic ceramide derivatives increase intracellular calcium levels and promote epidermal keratinocyte differentiation.
P2860
Q33916351-E47F0743-6304-4A9D-B63A-FBB60F15ACACQ34086280-D96649CC-8273-4E79-880F-7B721737DBA7Q34463964-3CCBFF17-98C1-4078-8CD3-C46D0600A591Q35903648-5FDC5AD0-DC95-4452-AA1D-D1C71555D4F8Q36696383-B0CE31E4-D6AB-4F55-91E5-8CF5DF6D7FAFQ37681786-284C6261-C653-49AD-B380-57175B25E623Q38718083-FD3A6C42-AD92-4C9A-B8ED-8E94083D3F64Q39117551-D44AC027-2A2A-4A30-ABB4-9D11607DDBEDQ42479062-1599EBE9-781E-4F48-80D6-7F2D9B173038Q44249342-7C9B6777-D2B2-46FA-80D7-128E35E3E81AQ44272174-053F1BC9-7C0E-413E-8B63-618DA2519C57Q48158721-069B671F-5D3C-4C3E-AEB4-05A48A7D01DCQ52645660-ACC401F8-3E0D-49DE-8CAC-83BA26A53520Q53568934-4C7BA6FC-DC70-4DF6-A491-910D984D354F
P2860
Pseudo-acylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid-deficient rats and has an inhibitory effect on epidermal hyperplasia
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@ast
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@en
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@nl
type
label
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@ast
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@en
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@nl
prefLabel
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@ast
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@en
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@nl
P2093
P2860
P356
P1476
Pseudo-acylceramide with linol ...... ffect on epidermal hyperplasia
@en
P2093
P2860
P356
10.1172/JCI117352
P407
P577
1994-07-01T00:00:00Z